Inventor
Rebecca HUTCHESON
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07DHeterocyclic compounds21%
A61KPreparations for medical, dental or toiletry purposes16%
C07KPeptides11%
C12NMicroorganisms or enzymes11%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
Y02ATechnologies for adaptation to climate change11%
PatentTitleYear
12,459,951Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease202512,391,705Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease202511,541,041Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease202311,213,515Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to SHY Therapeutics LLC (4)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SHY Therapeutics LLC | 4 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2025 |